Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2713-2717

  Pires, Isabel ^a   Queiroga, Felisbina Luisa ^a,b   Alves, Anabela ^a   Silva, Filipe ^b   Lopes, Carlos ^c  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Canine cutaneous histiocytoma; E cadherin; Immunohistochemistry; Tumour regression

Indexed keywords

UVOMORULIN;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CONTROLLED STUDY; HISTIOCYTOMA; KERATINOCYTE; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CADHERINS; DOGS; HISTIOCYTOMA, BENIGN FIBROUS; IMMUNOHISTOCHEMISTRY; NEOPLASM REGRESSION, SPONTANEOUS;

EID: 69249189530     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Coomer AR and Liptak JM: Canine histiocytic diseases. Compend Contin Educ Vet 30: 202-204, 2008.
2. Fulmer AK and Mauldin GE: Canine histiocytic neoplasia: an overview. Can Vet J 48: 1041-1043, 2007.
3. Kelly DF: Canine cutaneous histiocytoma. A light and electron microscopic study. Pathol Vet 7: 12-27, 1970.
4. Dobson JM, Samuel S, Milstein H, Rogers K and Wood JL: Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract 43: 240-246, 2002. (Pubitemid 135748518)
5. Pires MA, Travassos FS and Pires I: Neoplasias em canídeos. Um estudo retrospectivo de 6 anos. RPCV 98: 111-118, 2003.
6. Scott DW, Miller WH and Griffin CE: Neoplastic and non-neoplastic tumors. In: Muller & Kirk's Small Animal Dermatology. 6th edition. Philadelphia, W.B. Saunders Company, pp. 1346-1355, 2001.
7. Moore PF, Schrenzel MD, Affolter VK, Olivry T and Naydan D: Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules. Am J Pathol 148: 1699-1708, 1996. (Pubitemid 26135909)
8. Affolter VK and Moore PF: Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. Am J Dermatopathol 22: 40-48, 2000.
9. Affolter VK and Moore PF: Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 39: 74-83, 2002.
10. Marchal T, Dezutter-Dambuyant C, Fournel C, Magnol JP and Schmitt D: Immunophenotypic and ultrastructural evidence of the Langerhans cell origin of the canine cutaneous histiocytoma. Acta Anat (Basel) 153: 189-202, 1995.
11. Guvenc T, Haligur M, Orman MN and Haziroglu R: Mitosis and apoptosis in canine cutaneous histiocytoma and transmissible venereal tumour. Acta Vet Hung 50: 315-321, 2002. (Pubitemid 34983805)
12. Kaim U, Moritz A, Failing K and Baumgartner W: The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNA. Immunology 118: 472-482, 2006. (Pubitemid 44088354)
13. Kipar A, Baumgartner W, Kremmer E, Frese K and Weiss E: Expression of major histocompatibility complex class II antigen in neoplastic cells of canine cutaneous histiocytoma. Vet Immunol Immunopathol 62: 1-13, 1998. (Pubitemid 28234234)
14. Harrington KJ and Syrigos KN: The role of E-cadherin-catenin complex: more than an intercellular glue? Ann Surg Oncol 7: 783-788, 2000.
15. Suzuki SC and Takeichi M: Cadherins in neuronal morphogenesis and function. Dev Growth Differ 50: S119-130, 2008.
16. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991. (Pubitemid 121000430)
17. Gooding JM, Yap KL and Ikura M: The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays 26: 497-511, 2004.
18. Behrens J, Mareel MM, Van Roy FM and Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989. (Pubitemid 19168932)
19. De Matos AJ, Lopes CC, Faustino AM, Carvalheira JG, Rutteman GR and Gartner F: E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. APMIS 115: 327-334, 2007.
20. Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY: Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 52: 740-747, 2007. (Pubitemid 46898958)
21. Baines SJ, McInnes EF and McConnell I: E-cadherin expression in canine cutaneous histiocytomas. Vet Rec 162: 509-513, 2008.
22. Pires I, Alves A, Rodrigues P, Queiroga FL and Lopes CS: E-cadherin expression in canine cutaneous histiocytoma. Vet Rec 163: 59-60, 2008.
23. Hendrick MJ, Mahaffey EA, Moore FM, Vos JH and Walder EJ: Tumors of Vascular Tissue. Histological Classification of Mesenchymal Tumors of Skin and Soft Tissues of Domestic Animal. Washington: AFIP, pp. 22-24, 2008.
24. Cockerell GL and Slauson DO: Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma. J Comp Pathol 89: 193-203, 1979.
25. Gama A, Paredes J, Gartner F, Alves A and Schmitt F: Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Vet J 177: 45-53, 2008. (Pubitemid 351753675)
26. Marchal T, Saint-Andre I, Magnol JP, Dezutter-Dambuyant C and Schmitt D: Dendritic cells in dogs and cats: models of study in human pathology. Pathol Biol (Paris) 43: 910-920, 1995 (in French).
27. Tang A, Amagai M, Granger LG, Stanley JR and Udey MC: Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361: 82-85, 1993. (Pubitemid 23020779)
28. Jakob T, Brown MJ and Udey MC: Characterization of E-cadherin-containing junctions involving skin-derived dendritic cells. J Invest Dermatol J 112: 102-108, 1999. (Pubitemid 29024714)
29. Blauvelt A, Katz SI and Udey MC: Human Langerhans cells express E-cadherin. J Invest Dermatol 104: 293-296, 1995.
30. Chetty R, Serra S and Asa SL: Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Am J Surg Pathol 32: 413-419, 2008.
31. Chetty R and Serra S: Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology. Adv Anat Pathol 15: 234-240, 2008.
32. Morell-Quadreny L, Rubio J, Lopez-Guerrero JA, Casanova J, Ramos D, Iborra I, Solsona E and Llombart-Bosch A: Disruption of basement membrane, extracellular matrix metalloproteinases and E-cadherin in renal cell carcinoma. Anticancer Res 23: 5005-5010, 2003. (Pubitemid 38185793)
33. Chu YQ, Ye ZY, Tao HQ, Wang YY and Zhao ZS: Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World J Gastroenterol 14: 1990-1906, 2008.
34. Mitselou A, Ioachim E, Peschos D, Charalabopoulos K, Michael M, Agnantis NJ and Vougiouklakis T: E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Exp Oncol 29: 54-60, 2007. (Pubitemid 46713481)
35. Schwarzenberger K and Udey MC: Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 106: 553-558, 1996. (Pubitemid 26117590)
36. Cumberbatch M, Dearman RJ and Kimber I: Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison. Arch Dermatol Res 288: 739-744, 1996. (Pubitemid 26388131)
37. Fujita H, Asahina A and Tamaki K: Ligation of E-cadherin molecules on murine resident Langerhans cells inhibits their maturation and chemokine production. J Dermatol Sci 43: 152-155, 2006. (Pubitemid 44094001)
38. Riedl E, Stockl J, Majdic O, Scheinecker C, Knapp W and Strobl H: Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 96: 4276-4284, 2000.
39. McElligott J, McMichael A, Sangueza OP, Anthony E, Rose D and McLean TW: Spontaneous regression of Langerhans cell histiocytosis in a neonate with multiple bony lesions. J Pediatr Hematol Oncol 30: 85-86, 2008.
40. Yamaguchi S, Oki S and Kurisu K: Spontaneous regression of Langerhans cell histiocytosis: a case report. Surg Neurol 62: 136-140, 2004. (Pubitemid 38917089)
41. Jang KA, Ahn SJ, Choi JH, Sung KJ, Moon KC and Koh JK: Histiocytic disorders with spontaneous regression in infancy. Pediatr Dermatol 17: 364-368, 2000.
42. Miller MJ, Lonardo EC, Greer RD, Bevan C, Edwards DA, Smith JH, Freman JJ: Variable responses of species and strains to white mineral oils and paraffin waxes. Regul Toxicol Pharmacol 2: 55-68, 1996. (Pubitemid 26142909)
43. Bansal D, Marwaha RK, Trehan A, Gupta V and Varma N: Langerhans' cell histiocytosis: experience from a single center. Indian Pediatr 45: 685-688, 2008.
44. Goyal R, Das A, Nijhawan R, Bansal D and Marwaha RK: Langerhans cell histiocytosis infiltration into pancreas and kidney. Pediatr Blood Cancer 49: 748-750, 2007. (Pubitemid 350194447)
45. Terracciano L, Kocher T, Cathomas G, Bubendorf L and Lehmann FS: Langerhans cell histiocytosis of the stomach with atypical morphological features. Pathol Int 49: 553-556, 1999. (Pubitemid 29411171)
46. Geissmann F, Emile JF, Andry P, Thomas C, Fraitag S, De Prost Y, Brousse N: Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol 181: 301-304, 1997. (Pubitemid 27156843)
47. Kapur P, Erickson C, Rakheja D, Carder KR and Hoang MP: Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): ten-year experience at Dallas Children's Medical Center. J Am Acad Dermatol 56: 290-294, 2007. (Pubitemid 46074247)
48. Leenen PJ and Egeler RM: Langerhans' cell histiocytosis is caused by dysregulation of the E-cadherin-beta-catenin cascade: a hypothesis. Immunol Cell Biol 77: 460-467, 1999.
49. Beavon IR: The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 36: 1607-1620, 2000.
50. Wijnhoven BP, Dinjens WN and Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87: 992-1005, 2000.
51. Nakamura E, Sugihara H, Bamba M and Hattori T: Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol 205: 349-358, 2005. (Pubitemid 40253925)
52. Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Filipenko D, Huntsman D and Gilks B: Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. Am J Surg 191: 581-587, 2006.
53. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL and Brenner MB: Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 372: 190-193, 1994. (Pubitemid 24984663)
54. Marchal T, Dezutter-Dambuyant C, Fournel C, Magnol JP and Schmitt D: Electron microscopic study of canine cutaneous histiocytoma: a benign Langerhans cell tumor. Adv Exp Med Biol 378: 549-551, 1995.